Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKinsey
AstraZeneca
Moodys
Mallinckrodt

Last Updated: August 13, 2022

Investigational Drugs with Clinical Trials for: Peripheral Arterial Disease


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drugname Indication
PF-00489791 Peripheral Arterial Disease
Ataciguat Peripheral Arterial Disease
Succinic acid Peripheral Arterial Disease
>Drugname >Indication

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Dow
McKesson
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.